BSECompany Update4d ago · 24 Jul 2026, 07:13 pm
Attached
Dr. Lal PathLabs Ltd · 539524
✦ AI SummaryResults
Dr. Lal PathLabs Ltd has announced the availability of the audio recording of its earnings conference call with investors/analysts for Q1 FY27 on its website.
Analysis Scores
Earnings Impact8/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact9/10
Market Sentiment6/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Dr. Lal PathLabs Ltd - 539524 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Attachments (1)
📄pdf
Download →
ab26fe4c-7ed6-4bcc-b9f0-aca10512e055.pdf
View document text
July 24, 2026
National Stock Exchange of India Limited BSE Limited
Exchange Plaza, Corporate Relationship Department
Plot No. C/1, G Block, Phiroze Jeejeebhoy Towers
Bandra Kurla Complex, Bandra (E) Dalal Street
Mumbai – 400 051 Mumbai – 400 001
Symbol: LALPATHLAB Scrip Code: 539524
Sub: Audio Recording of Earnings Conference Call with Investors/ Analysts for Q1 FY27
Dear Sir / Madam,
Pursuant to Regulation 30 and 46(2) of the SEBI (Listing Obligations and Disclosure
Requirements) Regulations, 2015, please note that the audio recording of the Company’s
Conference Call dated July 24, 2026 with Investors/ Analysts for Q1 FY27 is available on the
Company’s website at https://www.lalpathlabs.com/investors/investors-inside/quarterly-result
We request you to please take the same on record.
Thanking You,
Yours Faithfully,
For Dr. Lal PathLabs Limited
Vinay Gujral
Company Secretary & Compliance Officer
Classification: Internal